When treated HNSCC cells with demethylation drug (DAC, 2.5 μM), the methylation levels of TIPE3 were decreased and the mRNA levels of TIPE3 were increased substantially (Fig. 1H, I, Supplementary Fig. 6). Here, TIPE3 is linked to head and neck squamous cell carcinoma.